Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) Authorized Dilution

Aurinia Pharmaceuticals Inc. Authorized Dilution

Share-issuance capacity and approved equity plans, with the disclosed share class, period, approval and expiry. Gross charter headroom is authorized minus issued shares, not a forecast. Equity plan reserves may use weighted counting rules, overlap charter capacity, and must not be added to it. Outstanding awards, future grants, and proposed approvals are distinct. * denotes calculated capacity.

As ofAuthorization / planShare classAuthorized / approved limit (shares)Issued shares / outstanding awards (shares)Remaining capacity (shares / reserve units)Approval statusApproval dateExpiry / conditionsBasis / limitationsSource

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B